1-20 of 81
Tatyana Feldman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Open-Label Phase 1 Study to Evaluate the Safety of SGN-35T in Patients with Relapsed/Refractory CD30-Expressing Lymphoid Malignancies (SGN35T-001; trial in progress)

Tatyana Feldman, Hun Ju Lee, Gizelle Popradi, Graham P. Collins, Daniel Morillo, Ming Jin Yan, Tara Chen, Youn H. Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 6356.
https://doi.org/10.1182/blood-2024-200265
Published: 2024
Journal Articles

Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Updated Follow-up of Transcend CLL 004

Tanya Siddiqi, Jordan Gauthier, Saad S. Kenderian, Danielle M. Brander, Kathleen Dorritie, Jacob D. Soumerai, Peter A. Riedell, Nirav N. Shah, Rajneesh Nath, Charalambos Andreadis, Daniel A. Ermann, Shuo Ma, Tatyana Feldman, Scott R. Solomon, Stephen J. Schuster, Sherilyn A. Tuazon, Serena K. Perna, San-San Ou, Neha Rane, Eniko Papp, Yizhe Chen, William G. Wierda
Journal: Blood
Blood (2024) 144 (Supplement 1): 4633.
https://doi.org/10.1182/blood-2024-200840
Published: 2024
Journal Articles

Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Leukemia, and Solid Tumors

Tatyana Feldman, Enrica Marchi, Stephen D. Smith, Adam J. Olszewski, Auris O Huen, Zachary D. Epstein-Peterson, Don A. Stevens, Alexander N. Starodub, Eric J. Feldman, Cristina P Rodriguez, John C. Reneau, Jonathan E. Brammer, Ahmad H. Mattour, Lauren C. Pinter-Brown, Rachelle Perea, Patrick Henrick, Joyoti Dey, Alyssa Fasciano, Rahul Karnik, Sagar Agarwal, Ashwin Gollerkeri, Jared Gollob, Aditi Shastri, Stefan K. Barta
Journal: Blood
Blood (2024) 144 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2024-210301
Published: 2024
Journal Articles

A Randomized Phase 2 Study Incorporating Nivolumab and Brentuximab Vedotin into Radiation-Free Treatment of Early Stage Classic Hodgkin Lymphoma

Ann S. LaCasce, Deepa Jagadeesh, Hun Ju Lee, Lu Chen, David A. Bond, Matthew Weinstock, Matthew Mei, Tatyana Feldman, Allison M. Winter, Jeffrey A. Barnes, Amitkumar N. Mehta, Gaurav Goyal, Sairah Ahmed, Lisa Giulino Roth, Azra Borogovac, Kristie A. Blum, Jane N Winter, Mehdi Hamadani, Sonali M. Smith, Philippe Armand, Ian W. Flinn, Jeremy S. Abramson, Alex F. Herrera
Journal: Blood
Blood (2024) 144 (Supplement 1): 459.
https://doi.org/10.1182/blood-2024-204113
Published: 2024
Journal Articles

PET-Directed Therapy with ABVD Vs. Bv+AVD Followed By Nivolumab in Patients with Early Stage Hodgkin Lymphoma: A Propensity Score Matched Analysis of CALGB50604 and ACCRULY1601

Steven I. Park, Stephen M. Ansell, Danielle Boselli, Sharmila Giri, Jakub Svoboda, Stephen D Smith, Tatyana Feldman, L. Elizabeth Budde, Andrew J Ness, Philip Bierman, Hun Ju Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 458.
https://doi.org/10.1182/blood-2024-202207
Published: 2024
Journal Articles

Improving Outcomes in Plasmablastic Lymphoma: A Multicenter Experience from an American Cohort

Matthew Hamby, Brian Egleston, Zachary AK Frosch, Raphael E. Steiner, Ariela Noy, Veronica Carvajal, Seda S. Tolu, Gaston Jean-Louis, Jennifer E. Amengual, Romil Patel, Sairah Ahmed, Timothy Voorhees, Robert Baiocchi, Andres Ramirez-Gamero, Jorge J. Castillo, Emily Hamburger, Christopher Dittus, Imran A. Nizamuddin, Neha Mehta-Shah, Nyein Nyein Thaw Dar, Jose Sandoval-Sus, Alexandra E. Rojek, Peter A. Riedell, Vinod Solipuram, Paul G. Rubinstein, Anthony Ariotti, Gita Suneja, Alexander Vartanov, Charles Milrod, Adam J. Olszewski, Gordon Smilnak, Emily Ayers, Sahaj Desai, Joanna M. Rhodes, Gabriella Magarelli, Tatyana Feldman, Meredith Pellon, David M. Aboulafia, William Bae, Carlos Galvez, Vineel Bhatlapenumarthi, Mehdi Hamadani, Stefan K. Barta
Journal: Blood
Blood (2024) 144 (Supplement 1): 573.
https://doi.org/10.1182/blood-2024-198008
Published: 2024
Journal Articles

3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma

Julie M. Vose, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Umar Farooq, Tatyana Feldman, Herve Ghesquieres, Wojciech Jurczak, Kim Linton, Catherine Thieblemont, Tycel J. Phillips, Won Seog Kim, Pegah Jafarinasabian, Barbara D'Angelo Månsson, David Soong, Andrew J. Steele, Zhu Li, Christian Eskelund, Martin Hutchings, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 4480.
https://doi.org/10.1182/blood-2024-198714
Published: 2024
Journal Articles

Lisocabtagene Maraleucel (liso-cel) Combined with Ibrutinib (ibr) for Patients (pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Primary Results from the Open-Label, Phase 1/2 Transcend CLL 004 Study

William G. Wierda, Kathleen Dorritie, Jordan Gauthier, Rajneesh Nath, Thomas J. Kipps, Peter A. Riedell, Herbert A. Eradat, Saad S. Kenderian, Mohamed A. Kharfan-Dabaja, Nirav N. Shah, Scott R. Solomon, Daniel A. Ermann, Jon E. Arnason, Abhinav Deol, Tatyana Feldman, Charalambos Andreadis, Monalisa Ghosh, Shuo Ma, Stephen J. Schuster, Usama Gergis, Julie M. Vose, Jacob D. Soumerai, Koen van Besien, Sherilyn A. Tuazon, Serena K. Perna, San-San Ou, Neha Rane, Eniko Papp, Yizhe Chen, Tanya Siddiqi
Journal: Blood
Blood (2024) 144 (Supplement 1): 887.
https://doi.org/10.1182/blood-2024-200339
Published: 2024
Journal Articles

Brentuximab Vedotin (BV) and Nivolumab (nivo) for Untreated Patients with Hodgkin Lymphoma (HL): Long-Term Results

Bruce D. Cheson, Nancy L. Bartlett, Betsy R. LaPlant, Hun Ju Lee, Ranjana H. Advani, Beth Christian, Catherine S. Diefenbach, Tatyana Feldman, Stephen M. Ansell
Journal: Blood
Blood (2024) 144 (Supplement 1): 3045.
https://doi.org/10.1182/blood-2024-207424
Published: 2024
Journal Articles

Investigating the Novel Combination of the Innate Cell Engager (ICE®) Acimtamig with Off-the-Shelf Allogeneic Natural Killer Cells AlloNK® in Relapsed or Refractory Classical Hodgkin Lymphoma (R/R cHL): Initial Results of the Phase 2 Luminice-203 Study

Joseph Maakaron, Dipenkumar Modi, Matthew Mei, Tatyana Feldman, Gunjan L. Shah, Amitkumar N. Mehta, Craig S. Sauter, Rashmi Khanal, Stefan K. Barta, Michael Emig, Lydia Wunderle, Andre Overesch, Alexandra Vasile, Jennifer Rubel, Thorsten Graef, Heather Raymon, Alison Moskowitz
Journal: Blood
Blood (2024) 144 (Supplement 1): 3052.
https://doi.org/10.1182/blood-2024-193896
Published: 2024
Journal Articles

Establishing Lymphoma Type-Specific Cytokine Signatures Using Tissue-Based RNA or Peripheral Blood Cell-Free RNA (cfRNA)

Maher Albitar, Hong Zhang, Sally Agersborg, Ahmad Charifa, Andrew L Pecora, Lori A. Leslie, Tatyana Feldman, Andrew Ip, Andre Goy
Journal: Blood
Blood (2024) 144 (Supplement 1): 4367.
https://doi.org/10.1182/blood-2024-203834
Published: 2024
Journal Articles

Polygenic HLA-Class I and HLA-Class II Models Define Various Types of Lymphoma

Maher Albitar, Hong Zhang, Andrew Ip, Gustavo A. Rivero, Wanlong Ma, Jeffrey Justin Estella, Lori A. Leslie, Tatyana Feldman, Ahmad Charifa, Arash Mohtashamian, Andrew L Pecora, Andre Goy
Journal: Blood
Blood (2023) 142 (Supplement 1): 6110.
https://doi.org/10.1182/blood-2023-187686
Published: 2023
Journal Articles

Brentuximab Vedotin, Nivolumab, Doxorubicin, and Dacarbazine for Advanced Stage Classical Hodgkin Lymphoma: Efficacy and Safety Results from the Single Arm Phase 2 Study

Hun Ju Lee, Ian W. Flinn, Jason Melear, Rod Ramchandren, Judah Friedman, John M. Burke, Yuliya Linhares, Paul Alan Gonzales, Mihir Raval, Rangaswamy Chintapatla, Tatyana Feldman, Habte A. Yimer, Miguel Islas-Ohlmayer, Asad Dean, Vishal Rana, Mitul Gandhi, John Scott Renshaw, Linda Ho, Michelle A. Fanale, Wenchuan Guo, Chris Yasenchak
Journal: Blood
Blood (2023) 142 (Supplement 1): 608.
https://doi.org/10.1182/blood-2023-173972
Published: 2023
Journal Articles

Preliminary Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

Aditi Shastri, Eric J Feldman, Alexander N Starodub, Tatyana Feldman, Cristina P Rodriguez, Zachary D. Epstein-Peterson, Don A. Stevens, Adam J Olszewski, Auris O Huen, Pierluigi Porcu, John C Reneau, Stefan K. Barta, Enrica Marchi, Ahmad H Mattour, Lauren C. Pinter-Brown, Rachelle Perea, Sean Donohue, Joyoti Dey, Sagar Agarwal, Rahul Karnik, Ashwin Gollerkeri, Jared Gollob, Stephen D Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 3081.
https://doi.org/10.1182/blood-2023-181130
Published: 2023
Journal Articles

Retrospective Review of Patients Treated with Intrathecal Rituximab for Primary and Secondary CNS Lymphoma and Leukemia

Tatyana Feldman, Alexandra Della Pia, Geeny Lee, Thomas S. Gunning, Michael Pelliccia, Tony Varughese, Harsh Parmar, Andrew Ip, Lori A. Leslie, Andre Goy, Samuel Singer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1773.
https://doi.org/10.1182/blood-2023-187164
Published: 2023
Journal Articles

Lisocabtagene Maraleucel (liso-cel) in R/R CLL/SLL: 24-Month Median Follow-up of TRANSCEND CLL 004

Tanya Siddiqi, David G Maloney, Saad S. Kenderian, Danielle M Brander, Kathleen Dorritie, Jacob Soumerai, Peter A Riedell, Nirav N. Shah, Rajneesh Nath, Bita Fakhri, Deborah M. Stephens, Shuo Ma, Tatyana Feldman, Scott R. Solomon, Stephen J. Schuster, Serena K. Perna, Sherilyn A. Tuazon, San-San Ou, Neha Rane, William G. Wierda
Journal: Blood
Blood (2023) 142 (Supplement 1): 330.
https://doi.org/10.1182/blood-2023-179529
Published: 2023
Journal Articles

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Hodgkin Lymphoma across the United States

Kathryn Lurain, Talal El Zarif, Ramya Ramaswami, Amin Nassar, Elio Adib, Noha Abdel-Wahab, Nikita Chintapally, Claire E. Drolen, Tatyana Feldman, Tarek Haykal, Caroline A. Nebhan, Swetha Kambhampati, Mingjia Li, Arjun Mittra, Michael Lorentsen, Chul Kim, Alexandra Drakaki, Michael Morse, Douglas B. Johnson, Ankit Mangla, Chris Dittus, Praful Ravi, Paul G. Rubinstein, Sarvari V. Yellapragada, Ann LaCasce, Guru P. Sonpavde, Abdul Rafeh Naqash, Alex F. Herrera
Journal: Blood
Blood (2023) 142 (Supplement 1): 3071.
https://doi.org/10.1182/blood-2023-174589
Published: 2023
Journal Articles

PET4 Response As an Independent Predictor of Long-Term Outcomes in ECHELON2 (A+CHP Vs. CHOP) in CD30+PTCL

Swami P. Iyer, Neha Mehta-Shah, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, Frank Morschhauser, EVA Domingo Domenech, Chiara Pagani, Won Seog Kim, Onder Alpdogan, Cheolwon Suh, Tatyana Feldman, Hervé Tilly, Pier Luigi Zinzani, Alessandro Rambaldi, David Belada, Jiri Mayer, Ilseung Choi, June-Won Cheong, Shweta Jain, Fenton Keenan, Michelle A. Fanale, Kerry J. Savage, Steven M. Horwitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 3074.
https://doi.org/10.1182/blood-2023-184933
Published: 2023
Journal Articles

Mitigating the Risk of Cytokine Release Syndrome (CRS): Preliminary Results from a DLBCL Cohort of Epcore NHL-1

Julie M. Vose, Tatyana Feldman, Martine E.D. Chamuleau, Won Seog Kim, Pieternella Lugtenburg, Tae Min Kim, Pau Abrisqueta Costa, Chan Y. Cheah, Ingrid Cecilia Glimelius, Brian Hess, Wojciech Jurczak, Gerardo Musuraca, Adam J. Olszewski, Minh Dinh, Nurgul Kilavuz, Monica Wielgos-Bonvallet, Tommy Li, Zhu Li, Christian Eskelund, Umar Farooq
Journal: Blood
Blood (2023) 142 (Supplement 1): 1729.
https://doi.org/10.1182/blood-2023-180333
Published: 2023
Journal Articles

Engraftment Syndrome during Autologous Stem Cell Transplant in Hodgkin Lymphoma Patients Treated with Checkpoint Inhibitors: A Multi-Center Retrospective Analysis

Eleanor Taranto, Wei-Ting Hwang, Maria Alfaro, Annika S Surapaneni, Sarvarinder Kaur Gill, Tatyana Feldman, Michael P Randall, Michael A Spinner, Fateeha Furqan, Nirav N. Shah, Yazeed Samara, Matthew G. Mei, Alex F. Herrera, Alison Moskowitz, Gunjan L. Shah, Jakub Svoboda
Journal: Blood
Blood (2023) 142 (Supplement 1): 3603.
https://doi.org/10.1182/blood-2023-187199
Published: 2023